Future Directions: Public Health The example of antimicrobial resistance

Similar documents
UK Five Year AMR Strategy ( ) Cheshire & Merseyside Health Protection CPD Event Tuesday 19 th November 2013

English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR)

Antimicrobial Resistance Update for Community Health Services

The UK 5-year AMR Strategy - a brief overview - Dr Berit Muller-Pebody National Infection Service Public Health England

Antimicrobial Resistance and Dentistry. LDC Officials Day 4 December 2015 Susie Sanderson

Introduction to antimicrobial resistance

The South African AMR strategy. 3 rd Annual Regulatory Workshop Gavin Steel Sector wide Procurement National Department of Health; South Africa

Antibiotic resistance is one of the biggest threats to global health, food security, and development today.

Models for stewardship in Hospital - UK Models Philip Howard Consultant Antimicrobial Pharmacist

ANTIMICROBIAL RESISTANCE: GLOBAL BURDEN

Evaluation of EU strategy to combat AMR

The UK strategy for antimicrobial resistance (AMR) and its implications for research and development

Joint Statement on Antimicrobial Resistance

Biology, Medicine, and Public Health Professor Cleaveland Lauren Dunn

WHO s first global report on antibiotic resistance reveals serious, worldwide threat to public health

Global Strategies to Address AMR Carmem Lúcia Pessoa-Silva, MD, PhD Antimicrobial Resistance Secretariat

STRICTLY EMBARGOED UNTIL 00:01 GMT, 22 MARCH 2016

Antimicrobial Stewardship. Where are we now and where do we need to go?

REPORT ON THE ANTIMICROBIAL RESISTANCE (AMR) SUMMIT

Antimicrobial Resistance, yes we care! The European Joint Action

Impact of Antimicrobial Resistance on Human Health. Robert Cunney HSE HCAI/AMR Programme and Temple Street Children s University Hospital

European challenges on antimicrobial resistance from a one health perspective Danish EU Presidency meeting, Copenhagen, 14 March 2012

OECD WORK ON AMR: TACKLING THE NEGATIVE CONSEQUENCES OF ANTIBIOTIC RESISTANCE ON HUMAN HEALTH. Michele Cecchini OECD Health Division

How is Ireland performing on antibiotic prescribing?

Antimicrobial Stewardship: The South African Perspective

Health Service Executive Parkgate St. Business Centre, Dublin 8 Tel:

2016/LSIF/FOR/004 Policies to Promote Patient Access to Innovative Treatments and Combat Antimicrobial Resistance

Safe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times

The South African Antimicrobial Resistance Strategy Framework

Impact of NHS England Quality Indicators on Antimicrobial Resistance. Professor Alan Johnson National Infection Service Public Health England

LIVING IN A POST-ANTIBIOTIC ERA: the impact on public health

Implementing the UK Five Year Antimicrobial Resistance Strategy

Antibiotic Resistance. A global view. Katia ISKANDAR RPh, Pharm.D, MHS, AMES, PhD candidate

ANTIMICROBIAL RESISTANCE THE AUSTRALIAN CONTEXT. Professor Brendan Murphy Australian Government Chief Medical Officer

M.L. Avent* 1,2, E.Waddell 1, K.Daveson 1 and K. Hajkowicz 1 1. Queensland Statewide Antimicrobial Stewardship 2. UQCCR, The University of Queensland

GHSA Prevent-1 (AMR) road map: Progress and implementation plan Dr. Anders Tegnell, Ministry of Health and Social Affairs, Sweden

WHO global and regional activities on AMR and collaboration with partner organisations

Dr Liz Tayler Antimicrobial Resistance Secretariat Global action plan on antimicrobial resistance

A THREE DIMENSIONAL REVIEW ON HUMAN IGNORANCE REGARDING ANTIMICROBIAL RESISTANCE

Infection control in intensive care. Sandra Fairley Senior Nurse, Neurocritical Care

The challenge of growing resistance

AMR situation in Europe: Strategy and vision

Table Of Content. Dutch EU Presidency Conference on Antimicrobial Resistance... 2 Summary... 3 Work Package... 8

Antimicrobial resistance and the need for stewardship. Dr Nick Brown RCP Acute Medicine conference, 16 April 2018

Dr Nata Menabde Executive Director World Health Organization Office at the United Nations Global action plan on antimicrobial resistance

COPING WITH ANTIMICROBIAL RESISTANCE

Council of the European Union Brussels, 13 June 2016 (OR. en)

Third Global Patient Safety Challenge. Tackling Antimicrobial Resistance

Council Conclusions on Antimicrobial Resistance (AMR) 2876th EMPLOYMENT, SOCIAL POLICY, HEALTH AND CONSUMER AFFAIRS Council meeting

Surveillance of AMR in PHE: a multidisciplinary,

Use of Antibiotics in Animals. A European Perspective by a Dutch observer. Dr. Albert Meijering

Managing AMR at the Human-Animal Interface. OIE Contributions to the AMR Global Action Plan

IFMSA Policy Proposal Antimicrobial Resistance

What is the problem? Latest data on antibiotic resistance

World Organisation for Animal Health

Advances in Antimicrobial Stewardship (AMS) at University Hospital Southampton

British Society for Antimicrobial Chemotherapy 53 Regent Place Birmingham B1 3NJ bsac.org.uk antibiotic action.com

Australia s response to the threat of antimicrobial resistance

These life-saving drugs have been a boon to medical care and benefited hundreds of million patients around the globe.

What s happening across the UK with antimicrobial prescribing quality indicators?

ANTIMICROBIAL RESISTANCE AND NATIONAL ACTION PLAN FOR PRUDENT USE OF ANTIMICROBIALS Egypt, GOVS 2017

Today s Agenda: 9/30/14

03/09/2014. Infection Prevention and Control A Foundation Course. Talk outline

UPDATE ON DEMONSTRATED RISKS IN HUMAN MEDICINE FROM RESISTANT PATHOGENS OF ANIMAL ORIGINS

A patient s guide to. MRSA - Methicillin Resistant Staphylococcus Aureus

WORLD ANTIBIOTIC AWARENESS WEEK

Antimicrobial Stewardship Northern Ireland

Dr Marc Sprenger Director Antimicrobial Resistance Secretariat Global action plan on antimicrobial resistance

Antimicrobial Resistance Prevention (Action Package: Prevent-1) Putting AMR on the priority list: Sweden Dr. Nils Anders Tegnell, Director, The

Vaccination as a potential strategy to combat Antimicrobial Resistance in the elderly

DR. BASHIRU BOI KIKIMOTO

TACKLING ANTIMICROBIAL RESISTANCE ENSURING SUSTAINABLE R&D

The European AMR Challenge - strategic views from the human perspective -

Initiatives taken to reduce antimicrobial resistance in DK and in the EU in the health care sector

How action in India can have global impact: The Indian pharmaceutical industry and antimicrobial resistance

MRSA found in British pig meat

Antimicrobial Resistance and Papua New Guinea WHY is it important? HOW has the problem arisen? WHAT can we do?

European Antibiotic Awareness Day

ECDC-EFSA-EMA Joint Opinion on Outcome Indicators on Surveillance of Antimicrobial Resistance and Use of Antimicrobials

Promoting Appropriate Antimicrobial Prescribing in Secondary Care

Global Communication on AMR in Animal Health: Tripartite and OIE Efforts

Dr Elisabeth Erlacher Vindel Head of Science and New Technologies Departement OIE AMR strategy and activities related to animal health

PACK-CXL. for infectious keratitis. Farhad Hafezi, MD PhD. Professor of Ophthalmology Keck School of Medicine USC Los Angeles, USA

Veterinary antimicrobials: state of play and future developments 2013 European Medicines Agency/IFAH- Europe Info Day 7-8 March 2013

EXPERIENCE ON ANTIMICROBIAL USE AND RESISTANCE IN KENYA

Role of the nurse in diagnosing infection: The right sample, every time

Antimicrobial resistance: the challenges for animal health

SECOND REPORT FROM THE COMMISSION TO THE COUNCIL

Why should we care about multi-resistant bacteria? Clinical impact and

Tackling the need for new antibacterial drugs

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY REFERENCES: MALTA, COUNTRY VISIT AMR. STOCKHOLM: ECDC; DG(SANTE)/

Antimicrobial Stewardship Esperienza Torinese

The role of FAO in AMR

Dr Mária Szabó Science and NewTechnologies Departement OIE AMR Strategy and the Prudent Use of Antimicrobials

Nosocomial Antibiotic Resistant Organisms

running head: SUPERBUGS Humphreys 1

Stratégie et action européennes

German Antimicrobial Resistance Strategy DART 2020

Promoting One Health : the international perspective OIE

Global Action Plan on AMR and Follow up

Transcription:

Future Directions: Public Health The example of antimicrobial resistance Valuing Our Life Support Systems Natural Capital Initiative British Library, 7 November 2014 Professor Anthony Kessel Director of International Public Health, Public Health England International Programme for Ethics, Public Health and Human Rights London School of Hygiene & Tropical Medicine

Outline of talk What is public health? The example of antimicrobial resistance Environmental philosophy and public health Conclusions

Definitions of public health..the art and science of preventing disease, promoting health, and prolonging life through organised efforts of society. Donald Acheson, London, 1988. Committee of Inquiry into the Future Development of the Public Health Function. Public health in England. London: HMSO, 1988. collective action in relation to the health of populations. Porter D. Health, civilization and the state: a history of public health from ancient to modern times. London: Routledge, 1999

Timeline I: Discovery of microbes and the first systematic infection control policies in hospitals Anton van Leeuwenhoek Florence Nightingale Joseph Lister 1676 1847 antiseptic hand wash proposition of germ theory causal link between bacteria and discovery of bacteria hygiene in field introduction of antiseptic disease 1840s hospitals 1864 surgery 1890 1870 Ignaz Semmelweiss Theory of Miasma Louis Pasteur Robert Koch Germ Theory

Timeline II: From germ theory to antimicrobial therapy William S. Halstead Alexander Fleming Selman Waksman 1890 Introduction of surgical masks 1928 discovery of sulfonamides 1943 introduction of surgical gloves 1897 discovery of penicillin 1932 Streptomycin is discovered Johannes Mikulicz-Radecki Pre-antibiotic age Gerhard Domagk Antibiotic age

Timeline III: From antimicrobial therapy to antimicrobial resistance Penicillin resistance First MDR case TB & MDR-TB global health emergency 1948 Resistance observed in Staphylococci Treatment for plant diseases 1952 1955 S. Dysaentriae outbreak in Japan Methicillin resistance in S. aureus 1961 1993 WHO declaration First confirmed case of completely drug-resistant TB in Mumbai* 2011 Streptomycin first used in agriculture Pre-antibiotic age First case of MRSA Complete drug resistance Post-antibiotic age? *http://www.bbc.co.uk/news/health-16592199

Global Picture: Antimicrobial Resistance World Health Organization 2014 surveillance report: very high rates of resistance have been observed in all WHO regions in common bacteria 8

There are significant gaps in global surveillance Many countries are reporting AMR data on less than 5/9 WHO microbes of international concern. Some of best data on AMR is from disease-specific programmes (e.g. TB).

Presentation title - edit in Header and Footer AMR in the United States

Antibiotic (mis)use drives resistance Global: 36% increase in consumption of antibiotic drugs (2000-2010) - increased consumption of carbapenems (45%) 11

UK 5-year AMR Strategy 2013-18 CMO Annual Report 2011* *published: March 2013 One Health Strategic aims 1. Improve the knowledge and understanding of AMR 2. Conserve and steward the effectiveness of existing treatments 3. Stimulate the development of new antibiotics, diagnostics and novel therapies 12

National actions (Surveillance) English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR) First ESAPUR report to be published in October 2014 13

Summary of 2014 ESPAUR Report Antibiotic resistance is a key threat to everyone s health and modern medical care. In England The number of patients with bloodstream infections has increased each year, 2010 to 2013 (e.g. 12% for E.coli) Increased numbers of these bloodstream infections are caused by resistant bacteria, 2010 to 2013 Antibiotic prescribing to patients has increased by 6% between 2010 to 2013 (GP 4% rise; Hospital 12% rise) Almost 80% of antibiotics are prescribed by General Practices Significant variability of resistance and antibiotics prescribing Concerning data for resistance and prescribing in England 14 ESPAUR data ESPAUR Report 2014

Significant regional prescribing variation General Practice Durham, Darlington and Tees, which was over 40% higher than London 26.5 compared to 18.9 DDD per 1000 Inhabitants per Day (DID) Hospital London twice Leicestershire and Lincolnshire 6.0 DID compared to 2.9 DID Total Merseyside, highest (similar to Southern Europe) over 30% higher Thames Valley 30.4 DID compared to 22.8 DID General Practice consumption by ATs, England, 2013 Hospital consumption, by ATs, England, 2013 Total consumption, by ATs, England, 2013

Global action on AMR World Health Assembly 2014 resolution Global Health Security Agenda: AMR action package - mechanism and collaboration to accelerate implementation WHO Global AMR Action Plan 2015 framework for action 16

René Descartes (31 March 1596 11 February 1650)

Immanuel Kant (22 April 1724 12 February 1804)

John Stuart Mill (20 May 1806 8 May 1873)

Environmental philosophy INSTRUMENTAL VALUE (moral worth) VS INTRINSIC / INHERENT VALUE (moral worth) ''Natural capital refers to the elements of nature that produce value (directly and indirectly) to people, such as the stock of forests, rivers, land, minerals and oceans. It includes the living aspects of nature (such as fish stocks) as well as the non-living aspects (such as minerals and energy resources). Natural capital underpins all other types of capital and is the foundation on which our economy, society and prosperity is built.'' - The Natural Capital Committee

Conclusions AMR a significant, (super)wicked, global issue Antibiotics are an invaluable societal resource BUT Truly tackling AMR necessitates a reconceptualisation of the natural environment as having inherent value and, therein, lies the future direction of public health 24